A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

NCT01042769 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7226

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Aleglitazar
DRUG: Placebo

Sponsor

Hoffmann-La Roche